ANNE BOTELER: Open Payments
NPI 1477287688 · SHREVEPORT, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,162 in 67 payments from 20 companies in 2025. Trend: 2023 $0 · 2024 $279 · 2025 $1,162
Food & beverage: $1,162
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $166 |
| Axsome Therapeutics, Inc. | 5 | $120 |
| PFIZER INC. | 7 | $116 |
| Lilly USA, LLC | 6 | $100 |
| Novo Nordisk Inc | 5 | $93 |
| Otsuka America Pharmaceutical, Inc. | 4 | $86 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $80 |
| Lundbeck LLC | 3 | $61 |
| Sumitomo Pharma America, Inc. | 3 | $51 |
| ABIOMED | 2 | $42 |
Products named: REXULTI, Auvelity, MOUNJARO, QULIPTA, TRINTELLIX, ELIQUIS, Wegovy, UBRELVY.
Industry payments across LA — which companies pay providers there.
